Perspectives on Behavioral Medicine Series – serie

A new attempt to acknowledge and rekindle interest in the experimental foundation of behavioral medicine, this volume focuses on the relevance of conditioning processes in the development of clinically relevant intervention strategies. It provides illustrations of the basic conditioning effects in the regulation of physiological responses, the role of conditioning in selected disease models, the precise application of conditioning principles, and speculative analyses of the potential of conditioning in the modification of clinically relevant responses. Issues involved in teaching both the fundamentals and the applied components of behavioral medicine are addressed.

This book focuses on the major issues surrounding worksite health promotion programs. It identifies and discusses examples of the most intensively studied programs (such as Johnson and Johnson's "Live for Life," and AT&T's "TLC"), and considers the "state of science" for the four most frequently offered health-promotion program components: smoking cessation, weight control, exercise, and stress management. As is becoming increasingly evident, worksite health-promotion activities pose their own unique set of challenges -- challenges that are likely to have a significant impact on national health status and costs. Crucial areas addressed in this volume include program development and design, cost benefit/cost effectiveness, and legislative/policy issues.

Smoking, diet, stress, coping, and exercise, among other behaviors and psychological states, are now clearly implicated in the development of cardiovascular diseases. Prevention, based largely on altering behaviors that contribute to this chronic disease, is now as important a goal as is treatment of those already afflicted. This volume, based on a recent meeting of the Academy of Behavioral Medicine Research, addresses several important areas of research in the general area of cardiovascular disease. The topics covered reflect on important aspects of this phenomenon, such as the long-term development of coronary artery disease; central nervous system (CNS) regulation of blood pressure, heart rate, and sympathetic tone playing a pivotal role in sympathetic activity and hypertension; learned blood pressure modulation and baroreceptor activation as a means of reducing the aversiveness of stress or noxious stimulation; and the notion that symptoms of heart disease or infarction may occur in the absence of organic heart disease. Having been impressed by the recent advances in the field, the editors of this book capture the wealth of newly acquired knowledge about behavioral factors in cardiovascular disease and how the body's nervous, endocrine, and cardiovascular systems work together.

This volume presents chapters by leading figures researching the various pathways by which stress may interfere with health maintenance and contribute to disease etiology and progression. Their work focuses on direct effects of stress on the immune and endocrine systems, on behavioral factors in diseases such as cancer and diabetes, and with the general role of stress in illness processes.

The number of, and interest in, quality of life studies has grown dramatically in the last decade. On an ever increasing basis, patients, clinicians, researchers, and health policy regulators are considering quality of life in assessing treatment alternatives. Unfortunately, most discussions of quality of life are narrow in scope -- applying to only one disease group. This unique book represents the concerted effort of experts in academia, federal government health care regulators, and pharmaceutical industry representatives to define the promise and the problems associated with quality of life studies. The issues covered range from cross cutting ones to those that are specific to particular illnesses.Because quality of life takes into consideration such domains as mood, vocation, family, sexual functioning, social participation, and costs, this book will serve as an invaluable companion to readers with an interest in behavioral medicine research.

Although considerable progress has been made in the understanding and treatment of a range of medical disorders, it had recently been pointed out that 85 percent of the population will be stricken by chronic disorders which may be accompanied by many years of suffering.This volume deals with issues of both cure and risk in chronic illnesses which are among the group of disorders associated with the leading causes of death in the United States at this time -- Alzheimer's disease, AIDS, and cancer. A consideration of the role of brain and behavior in relation to the cure and prevention of these disorders is the central focus of the various chapters in this book. Several chapters discuss the neuropsychological aspects of chronic illnesses including the underlying pathophysiology of changes in the brain which may be associated with both behavioral and physical signs and symptoms in these disorders. Considerable evidence suggests that a range of psychosocial or behavioral factors, such as stressful life events and depression, are associated with increased morbidity or mortality. Complex neurobiological pathways involving the brain, neurotransmitter, and neuroendocrine systems have been implicated. Other chapters consider some of the links among brain, behavior and chronic illnesses, as well as psychological factors such as coping and depression in relation to chronic disorders.The three leading risk factors known to be associated with both chronic illnesses and death -- diet, tobacco, and alcohol -- are all related to behavioral choices. Sexual behavior can be added to the list in terms of HIV infection and acquired immunodeficiency disease (AIDS). Several chapters deal specifically with a consideration of sexual behavior and HIV infection which clearly highlight the need for scientific knowledge in human sexuality if effective long term preventive measures are to be developed while waiting for a vaccine or cure.The search for cures must continue to have the highest priority in the scientific and clinical struggle against disease. Nonetheless, the value of psychosocial interventions on the quality of life and mental states of seriously ill persons should not be underestimated.

This book provides an illustrative overview of some of the key methodological and technical innovations that form the cutting edge of current research in behavioral medicine.It is divided into three sections. Part I consists of six chapters describing the impact on behavioral medicine research of novel developments in diverse areas such as molecular genetics, neuroendocrine assessment, laboratory radionuclide measurement of cardiac function, and the development of electronic event monitors for measuring compliance with medication regimens. In addition, new applications of long-available assessment techniques in clinical neuropsychology to behavioral issues in cardiovascular disease are reviewed.Part II includes four chapters which review methods and programs of research dealing with aspects of the ambulatory monitoring of moods and behavioral activities in conjunction with a variety of physiological processes and/or disease states.Finally, Part III provides two chapters which focus on novel theoretical and/or conceptual approaches--instead of the typical methodological innovations--that have guided recent research in behavioral oncology and in cardiovascular disease and the clustering syndrome of cardiovascular risk factors that relate to insulin metabolism.

A dramatic shift in the average age of the U.S. population and the increasing number of elderly Americans has introduced new and challenging healthcare dilemmas. This book addresses these issues with contributed chapters by the leading authorities in the field of behavioral medicine. It deals with health and healthcare needs of the elderly by considering basic changes that result from aging and some of the more specific problems that accompany it. Content highlights include a review of the basic tenets of genetics and molecular biology including some of the methods of looking at heritable differences in health and well-being. Quality of life concerns are addressed, including the differences between men and women, as well as other gender issues. Several chapters deal with the effects of aging on immunity. The latter part of the book emphasizes the psychosocial implications of aging on cardiovascular disease. Chronic illness among the elderly is also addressed.

First published in 1987. Routledge is an imprint of Taylor & Francis, an informa company.

This book provides an illustrative overview of some of the key methodological and technical innovations that form the cutting edge of current research in behavioral medicine.It is divided into three sections. Part I consists of six chapters describing the impact on behavioral medicine research of novel developments in diverse areas such as molecular genetics, neuroendocrine assessment, laboratory radionuclide measurement of cardiac function, and the development of electronic event monitors for measuring compliance with medication regimens. In addition, new applications of long-available assessment techniques in clinical neuropsychology to behavioral issues in cardiovascular disease are reviewed.Part II includes four chapters which review methods and programs of research dealing with aspects of the ambulatory monitoring of moods and behavioral activities in conjunction with a variety of physiological processes and/or disease states.Finally, Part III provides two chapters which focus on novel theoretical and/or conceptual approaches--instead of the typical methodological innovations--that have guided recent research in behavioral oncology and in cardiovascular disease and the clustering syndrome of cardiovascular risk factors that relate to insulin metabolism.

A dramatic shift in the average age of the U.S. population and the increasing number of elderly Americans has introduced new and challenging healthcare dilemmas. This book addresses these issues with contributed chapters by the leading authorities in the field of behavioral medicine. It deals with health and healthcare needs of the elderly by considering basic changes that result from aging and some of the more specific problems that accompany it. Content highlights include a review of the basic tenets of genetics and molecular biology including some of the methods of looking at heritable differences in health and well-being. Quality of life concerns are addressed, including the differences between men and women, as well as other gender issues. Several chapters deal with the effects of aging on immunity. The latter part of the book emphasizes the psychosocial implications of aging on cardiovascular disease. Chronic illness among the elderly is also addressed.

Smoking, diet, stress, coping, and exercise, among other behaviors and psychological states, are now clearly implicated in the development of cardiovascular diseases. Prevention, based largely on altering behaviors that contribute to this chronic disease, is now as important a goal as is treatment of those already afflicted. This volume, based on a recent meeting of the Academy of Behavioral Medicine Research, addresses several important areas of research in the general area of cardiovascular disease. The topics covered reflect on important aspects of this phenomenon, such as the long-term development of coronary artery disease; central nervous system (CNS) regulation of blood pressure, heart rate, and sympathetic tone playing a pivotal role in sympathetic activity and hypertension; learned blood pressure modulation and baroreceptor activation as a means of reducing the aversiveness of stress or noxious stimulation; and the notion that symptoms of heart disease or infarction may occur in the absence of organic heart disease. Having been impressed by the recent advances in the field, the editors of this book capture the wealth of newly acquired knowledge about behavioral factors in cardiovascular disease and how the body's nervous, endocrine, and cardiovascular systems work together.

The lack of balance and the failure of regulation in life has traditionally been recognized in such extreme symbolic acts as overconscientiousness or a criminal lack of conscience. This volume shows how the neurotic process affects biologic functions, distorting natural functioning. Three distinct functions and their respective extremes are discussed: eating (obesity, bulimia nervosa), sleeping (insomnia, excessive somnolence), and sex (hypersexuality including child molestation, hyposexuality including inhibited sexual desires).

A new attempt to acknowledge and rekindle interest in the experimental foundation of behavioral medicine, this volume focuses on the relevance of conditioning processes in the development of clinically relevant intervention strategies. It provides illustrations of the basic conditioning effects in the regulation of physiological responses, the role of conditioning in selected disease models, the precise application of conditioning principles, and speculative analyses of the potential of conditioning in the modification of clinically relevant responses. Issues involved in teaching both the fundamentals and the applied components of behavioral medicine are addressed.

Although considerable progress has been made in the understanding and treatment of a range of medical disorders, it had recently been pointed out that 85 percent of the population will be stricken by chronic disorders which may be accompanied by many years of suffering.This volume deals with issues of both cure and risk in chronic illnesses which are among the group of disorders associated with the leading causes of death in the United States at this time -- Alzheimer's disease, AIDS, and cancer. A consideration of the role of brain and behavior in relation to the cure and prevention of these disorders is the central focus of the various chapters in this book. Several chapters discuss the neuropsychological aspects of chronic illnesses including the underlying pathophysiology of changes in the brain which may be associated with both behavioral and physical signs and symptoms in these disorders. Considerable evidence suggests that a range of psychosocial or behavioral factors, such as stressful life events and depression, are associated with increased morbidity or mortality. Complex neurobiological pathways involving the brain, neurotransmitter, and neuroendocrine systems have been implicated. Other chapters consider some of the links among brain, behavior and chronic illnesses, as well as psychological factors such as coping and depression in relation to chronic disorders.The three leading risk factors known to be associated with both chronic illnesses and death -- diet, tobacco, and alcohol -- are all related to behavioral choices. Sexual behavior can be added to the list in terms of HIV infection and acquired immunodeficiency disease (AIDS). Several chapters deal specifically with a consideration of sexual behavior and HIV infection which clearly highlight the need for scientific knowledge in human sexuality if effective long term preventive measures are to be developed while waiting for a vaccine or cure.The search for cures must continue to have the highest priority in the scientific and clinical struggle against disease. Nonetheless, the value of psychosocial interventions on the quality of life and mental states of seriously ill persons should not be underestimated.

This book focuses on the major issues surrounding worksite health promotion programs. It identifies and discusses examples of the most intensively studied programs (such as Johnson and Johnson's "Live for Life," and AT&T's "TLC"), and considers the "state of science" for the four most frequently offered health-promotion program components: smoking cessation, weight control, exercise, and stress management. As is becoming increasingly evident, worksite health-promotion activities pose their own unique set of challenges -- challenges that are likely to have a significant impact on national health status and costs. Crucial areas addressed in this volume include program development and design, cost benefit/cost effectiveness, and legislative/policy issues.

The number of, and interest in, quality of life studies has grown dramatically in the last decade. On an ever increasing basis, patients, clinicians, researchers, and health policy regulators are considering quality of life in assessing treatment alternatives. Unfortunately, most discussions of quality of life are narrow in scope -- applying to only one disease group. This unique book represents the concerted effort of experts in academia, federal government health care regulators, and pharmaceutical industry representatives to define the promise and the problems associated with quality of life studies. The issues covered range from cross cutting ones to those that are specific to particular illnesses.Because quality of life takes into consideration such domains as mood, vocation, family, sexual functioning, social participation, and costs, this book will serve as an invaluable companion to readers with an interest in behavioral medicine research.